Cellular reprogramming for understanding and treating human disease

Frontiers in Cell and Developmental Biology

Volumn 2, Issue NOV, 2014, Pages

  Kanherkar, Riya R ^a   Bhatia Dey, Naina ^a   Makarev, Evgeny ^b   Csoka, Antonei B ^a  

^a HOWARD UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Disease; Epigenetics; Reprogramming; Stem cells

Indexed keywords

EID: 84961593462     PISSN: None     EISSN: 2296634X     Source Type: Journal    
DOI: 10.3389/fcell.2014.00067     Document Type: Review

References (188)

1. Abad, M., Mosteiro, L., Pantoja, C., Canamero, M., Rayon, T., Ors, I., et al. (2013). Reprogramming in vivo produces teratomas and iPS cells with totipotency features. Nature 502, 340-345. doi: 10.1038/nature12586
2. Abdelalim, E. M., Bonnefond, A., Bennaceur-Griscelli, A., and Froguel, P. (2014). Pluripotent stem cells as a potential tool for disease modeling and cell therapy in diabetes. Stem Cell Rev. 10, 327-337. doi: 10.1007/s12015-014-9503-6
3. Acimovic, I., Vilotic, A., Pesl, M., Lacampagne, A., Dvorak, P., Rotrekl, V., et al. (2014). Human pluripotent stem cell-derived cardiomyocytes as research and therapeutic tools. Biomed. Res. Int. 2014:512831. doi: 10.1155/2014/512831
4. Alberio, R., Campbell, K. H., and Johnson, A. D. (2006). Reprogramming somatic cells into stem cells. Reproduction 132, 709-720. doi: 10.1530/rep.1.01077
5. An, M. C., O'brien, R. N., Zhang, N., Patra, B. N., De La Cruz, M., Ray, A., et al. (2014). Polyglutamine disease modeling: epitope based screen for homologous recombination using CRISPR/Cas9 system. PLoS Curr. 6:ecurrents.hd.0242d2e7ad72225efa72f6964589369a. doi: 10.1371/currents.hd.0242d2e7ad72225efa72f6964589369a
6. Anna, B., Blazej, Z., Jacqueline, G., Andrew, C. J., Jeffrey, R., and Andrzej, S. (2007). Mechanism of UV-related carcinogenesis and its contribution to nevi/melanoma. Expert Rev. Dermatol. 2, 451-469. doi: 10.1586/17469872.2.4.451
7. Apostolou, E., and Hochedlinger, K. (2013). Chromatin dynamics during cellular reprogramming. Nature 502, 462-471. doi: 10.1038/nature12749
8. Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., and Yildiz, B. O. (2004). The prevalence and features of the polycystic ovary syndrome in an unselected population. J. Clin. Endocrinol. Metab. 89, 2745-2749. doi: 10.1210/jc.2003-032046
9. Ballios, B. G., Clarke, L., Coles, B. L., Shoichet, M. S., and Van Der Kooy, D. (2012). The adult retinal stem cell is a rare cell in the ciliary epithelium whose progeny can differentiate into photoreceptors. Biol. Open 1, 237-246. doi: 10.1242/bio.2012027
10. Batista, L. F. (2014). Telomere biology in stem cells and reprogramming. Prog. Mol. Biol. Transl. Sci. 125, 67-88. doi: 10.1016/B978-0-12-397898-1.00003-7
11. Berger, S. L., Kouzarides, T., Shiekhattar, R., and Shilatifard, A. (2009). An operational definition of epigenetics. Genes Dev. 23, 781-783. doi: 10.1101/gad.1787609
12. Berthiaume, F., Maguire, T. J., and Yarmush, M. L. (2011). Tissue engineering and regenerative medicine: history, progress, and challenges. Annu. Rev. Chem. Biomol. Eng. 2, 403-430. doi: 10.1146/annurev-chembioeng-061010-114257
13. Bhattacharyya, S., Kumar, A., and Lal Khanduja, K. (2012). The voyage of stem cell toward terminal differentiation: a brief overview. Acta Biochim. Biophys. Sin. (Shanghai). 44, 463-475. doi: 10.1093/abbs/gms027
14. Bieback, K., Kinzebach, S., and Karagianni, M. (2011). Translating research into clinical scale manufacturing of mesenchymal stromal cells. Stem Cells Int. 2010:193519. doi: 10.4061/2010/193519
15. Bienvenu, T., Carrie, A., De Roux, N., Vinet, M. C., Jonveaux, P., Couvert, P., et al. (2000). MECP2 mutations account for most cases of typical forms of Rett syndrome. Hum. Mol. Genet. 9, 1377-1384. doi: 10.1093/hmg/9.9.1377
16. Bird, A. (2007). Perceptions of epigenetics. Nature 447, 396-398. doi: 10.1038/nature05913
17. Bjornsson, H. T., Fallin, M. D., and Feinberg, A. P. (2004). An integrated epigenetic and genetic approach to common human disease. Trends Genet. 20, 350-358. doi: 10.1016/j.tig.2004.06.009
18. Bredenkamp, N., Nowell, C. S., and Blackburn, C. C. (2014). Regeneration of the aged thymus by a single transcription factor. Development 141, 1627-1637. doi: 10.1242/dev.103614
19. Brenchley, J. M., Schacker, T. W., Ruff, L. E., Price, D. A., Taylor, J. H., Beilman, G. J., et al. (2004). CD4+T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200, 749-759. doi: 10.1084/jem.20040874
20. Briggs, R., and King, T. J. (1952). Transplantation of living nuclei from blastula cells into enucleated Frogs' eggs. Proc. Natl. Acad. Sci. U.S.A. 38, 455-463
21. Buganim, Y., Faddah, D. A., Cheng, A. W., Itskovich, E., Markoulaki, S., Ganz, K., et al. (2012). Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase. Cell 150, 1209-1222. doi: 10.1016/j.cell.2012.08.023
22. Campbell, K. H., Fisher, P., Chen, W. C., Choi, I., Kelly, R. D., Lee, J. H., et al. (2007). Somatic cell nuclear transfer: past, present and future perspectives. Theriogenology 68(Suppl. 1), S214-S231. doi: 10.1016/j.theriogenology.2007.05.059
23. Campbell, K. H., McWhir, J., Ritchie, W. A., and Wilmut, I. (1996). Sheep cloned by nuclear transfer from a cultured cell line. Nature 380, 64-66. doi: 10.1038/380064a0
24. Campisi, J. (2001). Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 11, S27-S31. doi: 10.1016/S0962-8924(01)02151-1
25. Campisi, J. (2005). Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120, 513-522. doi: 10.1016/j.cell.2005.02.003
26. Campisi, J., and Vijg, J. (2009). Dos damage to DNA and other macromolecules play a role in aging? If so, how? J. Gerentol. A. Biol. Sci. 64, 4. doi: 10.1093/gerona/gln065
27. Campos-Sanchez, E., and Cobaleda, C. (2014). Tumoral reprogramming: plasticity takes a walk on the wild side. Biochim. Biophys. Acta. doi: 10.1016/j.bbagrm.2014.07.003. [Epub ahead of print]
28. Chakravarthy, U., Wong, T. Y., Fletcher, A., Piault, E., Evans, C., Zlateva, G., et al. (2010). Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol. 10:31. doi: 10.1186/1471-2415-10-31
29. Chen, Q. W., Zhu, X. Y., Li, Y. Y., and Meng, Z. Q. (2014). Epigenetic regulation and cancer (Review). Oncol. Rep. 31, 523-532. doi: 10.3892/or.2013.2913
30. Cherry, A. B., and Daley, G. Q. (2012). Reprogramming cellular identity for regenerative medicine. Cell 148, 1110-1122. doi: 10.1016/j.cell.2012.02.031
31. Colwell, A. S., Longaker, M. T., and Lorenz, H. P. (2005). Mammalian fetal organ regeneration. Adv. Biochem. Eng. Biotechnol. 93, 83-100. doi: 10.1007/b99972
32. Conboy, I. M., Conboy, M. J., Wagers, A. J., Girma, E. R., Weissman, I. L., and Rando, T. A. (2005). Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433, 760-764. doi: 10.1038/nature03260
33. Conboy, M. J., Conboy, I. M., and Rando, T. A. (2013). Heterochronic parabiosis: historical perspective and methodological considerations for studies of aging and longevity. Aging Cell 12, 525-530. doi: 10.1111/acel.12065
34. Constantinescu, D., Gray, H. L., Sammak, P. J., Schatten, G. P., and Csoka, A. B. (2006). Lamin A/C expression is a marker of mouse and human embryonic stem cell differentiation. Stem Cells 24, 177-185. doi: 10.1634/stemcells.2004-0159
35. Cook, H. L., Patel, P. J., and Tufail, A. (2008). Age-related macular degeneration: diagnosis and management. Br. Med. Bull. 85, 127-149. doi: 10.1093/bmb/ldn012
36. Costa, E., Chen, Y., Davis, J., Dong, E., Noh, J. S., Tremolizzo, L., et al. (2002). REELIN and schizophrenia: a disease at the interface of the genome and the epigenome. Mol. Interv. 2, 47-57. doi: 10.1124/mi.2.1.47
37. Csobonyeiova, M., Polak, S., Koller, J., and Danisovic, L. (2014). Induced pluripotent stem cells and their implication for regenerative medicine. Cell Tissue Bank. doi: 10.1007/s10561-014-9462-9. [Epub ahead of print]
38. De Los Angeles, A., and Daley, G. Q. (2013). Stem cells: reprogramming in situ. Nature 502, 309-310. doi: 10.1038/nature12559
39. De Robertis, E. M. (2006). Spemann's organizer and self-regulation in amphibian embryos. Nat. Rev. Mol. Cell Biol. 7, 296-302. doi: 10.1038/nrm1855
40. Diamanti-Kandarakis, E., Kandarakis, H., and Legro, R. S. (2006). The role of genes and environment in the etiology of PCOS. Endocrine 30, 19-26. doi: 10.1385/ENDO:30:1:19
41. Ehrlich, M. (2003). The ICF syndrome, a DNA methyltransferase 3B deficiency and immunodeficiency disease. Clin. Immunol. 109, 17-28. doi: 10.1016/S1521-6616(03)00201-8
42. Eminli, S., Foudi, A., Stadtfeld, M., Maherali, N., Ahfeldt, T., Mostoslavsky, G., et al. (2009). Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat. Genet. 41, 968-976. doi: 10.1038/ng.428
43. Eriksson, M., Brown, W. T., Gordon, L. B., Glynn, M. W., Singer, J., Scott, L., et al. (2003). Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 423, 293-298. doi: 10.1038/nature01629
44. Escobar-Morreale, H. F., Luque-Ramirez, M., and San Millan, J. L. (2005). The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocr. Rev. 26, 251-282. doi: 10.1210/er.2004-0004
45. Ess, K. C. (2013). Patient heal thyself: modeling and treating neurological disorders using patient-derived stem cells. Exp. Biol. Med. (Maywood). 238, 308-314. doi: 10.1177/1535370213480713
46. Esteller, M., Corn, P. G., Baylin, S. B., and Herman, J. G. (2001). A gene hypermethylation profile of human cancer. Cancer Res. 61, 3225-3229
47. Evans, M. J., and Kaufman, M. H. (1981). Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154-156
48. Festuccia, N., Osorno, R., Wilson, V., and Chambers, I. (2013). The role of pluripotency gene regulatory network components in mediating transitions between pluripotent cell states. Curr. Opin. Genet. Dev. 23, 504-511. doi: 10.1016/j.gde.2013.06.003
49. Fisher, M. B., and Mauck, R. L. (2013). Tissue engineering and regenerative medicine: recent innovations and the transition to translation. Tissue Eng. Part B Rev. 19, 1-13. doi: 10.1089/ten.TEB.2012.0723
50. Fritz, A. L., Mao, S. R., West, M. G., and Schaffer, D. V. (2014). A medium-throughput analysis of signaling pathways involved in early stages of stem cell reprogramming. Biotechnol. Bioeng. doi: 10.1002/bit.25336. [Epub ahead of print]
51. Frobel, J., Hemeda, H., Lenz, M., Abagnale, G., Joussen, S., Denecke, B., et al. (2014). Epigenetic rejuvenation of mesenchymal stromal cells derived from induced pluripotent stem cells. Stem Cell Reports 3, 414-422. doi: 10.1016/j.stemcr.2014.07.003
52. Fulda, S., Gorman, A. M., Hori, O., and Samali, A. (2010). Cellular stress responses: cell survival and cell death. Int. J. Cell Biol. 2010:214074. doi: 10.1155/2010/214074
53. Gafni, O., Weinberger, L., Mansour, A. A., Manor, Y. S., Chomsky, E., Ben-Yosef, D., et al. (2013). Derivation of novel human ground state naive pluripotent stem cells. Nature 504, 282-286. doi: 10.1038/nature12745
54. Gaj, T., Gersbach, C. A., and Barbas, C. F. 3rd. (2013). ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol. 31, 397-405. doi: 10.1016/j.tibtech.2013.04.004
55. Gardner, R. L. (2002). Stem cells: potency, plasticity and public perception. J. Anat. 200, 277-282. doi: 10.1046/j.1469-7580.2002.00029.x
56. George, B. (2011). Regulations and guidelines governing stem cell based products: clinical considerations. Perspect. Clin. Res. 2, 94-99. doi: 10.4103/2229-3485.83228
57. Gimble, J. M., Katz, A. J., and Bunnell, B. A. (2007). Adipose-derived stem cells for regenerative medicine. Circ. Res. 100, 1249-1260. doi: 10.1161/01.RES.0000265074.83288.09
58. Graf, T. (2011). Historical origins of transdifferentiation and reprogramming. Cell Stem Cell 9, 504-516. doi: 10.1016/j.stem.2011.11.012
59. Grskovic, M., Javaherian, A., Strulovici, B., and Daley, G. Q. (2011). Induced pluripotent stem cells-opportunities for disease modeling and drug discovery. Nat. Rev. Drug Discov. 10, 915-929. doi: 10.1038/nrd3577
60. Grunz, H. (2001). Developmental biology of amphibians after Hans Spemann in Germany. Int. J. Dev. Biol. 45, 39-50
61. Guha, P., Morgan, J. W., Mostoslavsky, G., Rodrigues, N. P., and Boyd, A. S. (2013). Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. Cell Stem Cell 12, 407-412. doi: 10.1016/j.stem.2013.01.006
62. Gurdon, J. B. (1962). The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. J. Embryol. Exp. Morphol. 10, 622-640
63. Gurdon, J. B., and Melton, D. A. (2008). Nuclear reprogramming in cells. Science 322, 1811-1815. doi: 10.1126/science.1160810
64. Gurtner, G. C., Callaghan, M. J., and Longaker, M. T. (2007). Progress and potential for regenerative medicine. Annu. Rev. Med. 58, 299-312. doi: 10.1146/annurev.med.58.082405.095329
65. Gurtner, G. C., Werner, S., Barrandon, Y., and Longaker, M. T. (2008). Wound repair and regeneration. Nature 453, 314-321. doi: 10.1038/nature07039
66. Halley-Stott, R. P., Pasque, V., and Gurdon, J. B. (2013). Nuclear reprogramming. Development 140, 2468-2471. doi: 10.1242/dev.092049
67. Hanahan, D., and Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell 144, 646-674. doi: 10.1016/j.cell.2011.02.013
68. Hanna, J., Wernig, M., Markoulaki, S., Sun, C. W., Meissner, A., Cassady, J. P., et al. (2007). Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318, 1920-1923. doi: 10.1126/science.1152092
69. Hansson, J., Rafiee, M. R., Reiland, S., Polo, J. M., Gehring, J., Okawa, S., et al. (2012). Highly coordinated proteome dynamics during reprogramming of somatic cells to pluripotency. Cell Rep. 2, 1579-1592. doi: 10.1016/j.celrep.2012.10.014
70. Harries, L. W., Pilling, L. C., Hernandez, L. D., Bradley-Smith, R., Henley, W., Singleton, A. B., et al. (2012). CCAAT-enhancer-binding protein-beta expression in vivo is associated with muscle strength. Aging Cell 11, 262-268. doi: 10.1111/j.1474-9726.2011.00782.x
71. Health, U. S. D. O., Human Services, F., and Drug Administration, C. F. B. E. (2001). Guidance for human somatic cell therapy and gene therapy. Hum. Gene Ther. 12, 303-314. doi: 10.1089/10430340150218431
72. Heller, J. P., and Martin, K. R. (2014). Enhancing RPE cell-based therapy outcomes for AMD: the role of Bruch's membrane. Transl. Vis. Sci. Technol. 3:11. doi: 10.1167/tvst.3.3.11
73. Hewagama, A., and Richardson, B. (2009). The genetics and epigenetics of autoimmune diseases. J. Autoimmun. 33, 3-11. doi: 10.1016/j.jaut.2009.03.007
74. Hibaoui, Y., Grad, I., Letourneau, A., Sailani, M. R., Dahoun, S., Santoni, F. A., et al. (2014). Modeling and rescuing neurodevelopmental defect of down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21. EMBO Mol. Med. 6, 259-277. doi: 10.1002/emmm.201302848
75. High, K., Gregory, P. D., and Gersbach, C. (2014). CRISPR technology for gene therapy. Nat. Med. 20, 476-477. doi: 10.1038/nm.3566
76. Holt, N., Wang, J., Kim, K., Friedman, G., Wang, X., Taupin, V., et al. (2010). Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat. Biotechnol. 28, 839-847. doi: 10.1038/nbt.1663
77. Horvath, S. (2013). DNA methylation age of human tissues and cell types. Genome Biol. 14:R115. doi: 10.1186/gb-2013-14-10-r115
78. Hou, P., Li, Y., Zhang, X., Liu, C., Guan, J., Li, H., et al. (2013). Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 341, 651-654. doi: 10.1126/science.1239278
79. Hu, K., Yu, J., Suknuntha, K., Tian, S., Montgomery, K., Choi, K. D., et al. (2011). Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells. Blood 117, e109-e119. doi: 10.1182/blood-2010-07-298331
80. Hutter, G., Nowak, D., Mossner, M., Ganepola, S., Mussig, A., Allers, K., et al. (2009). Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N. Engl. J. Med. 360, 692-698. doi: 10.1056/NEJMoa0802905
81. International Stem Cell, I., Adewumi, O., Aflatoonian, B., Ahrlund-Richter, L., Amit, M., Andrews, P. W., et al. (2007). Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat. Biotechnol. 25, 803-816. doi: 10.1038/nbt1318
82. Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., and Forman, D. (2011). Global cancer statistics. CA Cancer J. Clin. 61, 69-90. doi: 10.3322/caac.20107
83. Jeon, K., Lim, H., Kim, J. H., Thuan, N. V., Park, S. H., Lim, Y. M., et al. (2012). Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model. Stem Cells Dev. 21, 2642-2655. doi: 10.1089/scd.2011.0665
84. Jiang, Y., Jahagirdar, B. N., Reinhardt, R. L., Schwartz, R. E., Keene, C. D., Ortiz-Gonzalez, X. R., et al. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41-49. doi: 10.1038/nature00870
85. Kallings, L. O. (2008). The first postmodern pandemic: 25 years of HIV/AIDS. J. Intern. Med. 263, 218-243. doi: 10.1111/j.1365-2796.2007.01910.x
86. Kambal, A., Mitchell, G., Cary, W., Gruenloh, W., Jung, Y., Kalomoiris, S., et al. (2011). Generation of HIV-1 resistant and functional macrophages from hematopoietic stem cell-derived induced pluripotent stem cells. Mol. Ther. 19, 584-593. doi: 10.1038/mt.2010.269
87. Kanherkar, R. R., Bhatia-Dey, N., and Csoka, A. B. (2014). Epigenetics across the human lifespan. Front. Cell Dev. Biol. 2:49. doi: 10.3389/fcell.2014.00049
88. Kator, K., Cristofalo, V., Charpentier, R., and Cutler, R. G. (1985). Dysdifferentiative nature of aging: passage number dependency of globin gene expression in normal human diploid cells grown in tissue culture. Gerontology 31, 355-361
89. Kikyo, N., and Wolffe, A. P. (2000). Reprogramming nuclei: insights from cloning, nuclear transfer and heterokaryons. J. Cell Sci. 113(Pt 1), 11-20
90. Kim, H., and Kim, J. S. (2014). A guide to genome engineering with programmable nucleases. Nat. Rev. Genet. 15, 321-334. doi: 10.1038/nrg3686
91. Kim, J., Efe, J. A., Zhu, S., Talantova, M., Yuan, X., Wang, S., et al. (2011). Direct reprogramming of mouse fibroblasts to neural progenitors. Proc. Natl. Acad. Sci. U.S.A. 108, 7838-7843. doi: 10.1073/pnas.1103113108
92. Kleivi, K. (2006). Advances in the genetics and epigenetics of gene regulation and human disease. Genome Biol. 7:325. doi: 10.1186/gb-2006-7-8-325
93. Korf, B. (2008). Hutchinson-Gilford progeria syndrome, aging, and the nuclear lamina. N. Engl. J. Med. 358, 552-555. doi: 10.1056/NEJMp0800071
94. Kriks, S., Shim, J. W., Piao, J., Ganat, Y. M., Wakeman, D. R., Xie, Z., et al. (2011). Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 480, 547-551. doi: 10.1038/nature10648
95. Lang, A. H., Li, H., Collins, J. J., and Mehta, P. (2014). Epigenetic landscapes explain partially reprogrammed cells and identify key reprogramming genes. PLoS Comput. Biol. 10:e1003734. doi: 10.1371/journal.pcbi.1003734
96. Lapasset, L., Milhavet, O., Prieur, A., Besnard, E., Babled, A., Ait-Hamou, N., et al. (2011). Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state. Genes Dev. 25, 2248-2253. doi: 10.1101/gad.173922.111
97. Ledran, M. H., Krassowska, A., Armstrong, L., Dimmick, I., Renstrom, J., Lang, R., et al. (2008). Efficient hematopoietic differentiation of human embryonic stem cells on stromal cells derived from hematopoietic niches. Cell Stem Cell 3, 85-98. doi: 10.1016/j.stem.2008.06.001
98. Lenhoff, H. M. (1991). Ethel Browne, Hans Spemann, and the discovery of the discovery of the oganiser phenomenon. Biol. Bull. 181, 72-80
99. Li, J., Song, W., Pan, G., and Zhou, J. (2014). Advances in understanding the cell types and approaches used for generating induced pluripotent stem cells. J. Hematol. Oncol. 7, 50. doi: 10.1186/s13045-014-0050-z
100. Li, L., and Bhatia, R. (2011). Stem cell quiescence. Clin. Cancer Res. 17, 4936-4941. doi: 10.1158/1078-0432.CCR-10-1499
101. Liang, G., and Zhang, Y. (2013). Embryonic stem cell and induced pluripotent stem cell: an epigenetic perspective. Cell Res. 23, 49-69. doi: 10.1038/cr.2012.175
102. Lisanti, S., Tavecchio, M., Chae, Y. C., Liu, Q., Brice, A. K., Thakur, M. L., et al. (2014). Deletion of the mitochondrial chaperone TRAP-1 uncovers global reprogramming of metabolic networks. Cell Rep. 8, 671-677. doi: 10.1016/j.celrep.2014.06.061
103. Liu, B., Hunter, D. J., Rooker, S., Chan, A., Paulus, Y. M., Leucht, P., et al. (2013a). Wnt signaling promotes muller cell proliferation and survival after injury. Invest. Ophthalmol. Vis. Sci. 54, 444-453. doi: 10.1167/iovs.12-10774
104. Liu, G. H., Barkho, B. Z., Ruiz, S., Diep, D., Qu, J., Yang, S. L., et al. (2011a). Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Nature 472, 221-225. doi: 10.1038/nature09879
105. Liu, G. H., Suzuki, K., Li, M., Qu, J., Montserrat, N., Tarantino, C., et al. (2014). Modeling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs. Nat. Commun. 5, 4330. doi: 10.1038/ncomms5330
106. Liu, G. H., Suzuki, K., Qu, J., Sancho-Martinez, I., Yi, F., Li, M., et al. (2011b). Targeted gene correction of laminopathy-associated LMNA mutations in patient-specific iPSCs. Cell Stem Cell 8, 688-694. doi: 10.1016/j.stem.2011.04.019
107. Liu, Y., Weick, J. P., Liu, H., Krencik, R., Zhang, X., Ma, L., et al. (2013b). Medial ganglionic eminence-like cells derived from human embryonic stem cells correct learning and memory deficits. Nat. Biotechnol. 31, 440-447. doi: 10.1038/nbt.2565
108. Loffredo, F. S., Steinhauser, M. L., Jay, S. M., Gannon, J., Pancoast, J. R., Yalamanchi, P., et al. (2013). Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell 153, 828-839. doi: 10.1016/j.cell.2013.04.015
109. Loh, K. M., and Lim, B. (2012). Epigenetics: actors in the cell reprogramming drama. Nature 488, 599-600. doi: 10.1038/488599a
110. Luna-Zurita, L., and Bruneau, B. G. (2013). Chromatin modulators as facilitating factors in cellular reprogramming. Curr. Opin. Genet. Dev. 23, 556-561. doi: 10.1016/j.gde.2013.07.002
111. Lunyak, V. V., and Rosenfeld, M. G. (2008). Epigenetic regulation of stem cell fate. Hum. Mol. Genet. 17, R28-R36. doi: 10.1093/hmg/ddn149
112. Ma, T., Xie, M., Laurent, T., and Ding, S. (2013). Progress in the reprogramming of somatic cells. Circ. Res. 112, 562-574. doi: 10.1161/CIRCRESAHA.111.249235
113. Manikkam, M., Tracey, R., Guerrero-Bosagna, C., and Skinner, M. K. (2012). Pesticide and insect repellent mixture (permethrin and DEET) induces epigenetic transgenerational inheritance of disease and sperm epimutations. Reprod. Toxicol. 34, 708-719. doi: 10.1016/j.reprotox.2012.08.010
114. Manukyan, M., and Singh, P. B. (2012). Epigenetic rejuvenation. Genes Cells 17, 337-343. doi: 10.1111/j.1365-2443.2012.01595.x
115. Martin, G. R. (1981). Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. U.S.A. 78, 7634-7638
116. Mason, J. L., Jones, J. J., Taniike, M., Morell, P., Suzuki, K., and Matsushima, G. K. (2000). Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination. J. Neurosci. Res. 61, 251-262. doi: 10.1002/1097-4547(20000801)61:3%3C251::AID-JNR3%3E3.0.CO;2-W
117. McClintock, D., Ratner, D., Lokuge, M., Owens, D. M., Gordon, L. B., Collins, F. S., et al. (2007). The mutant form of lamin A that causes Hutchinson-Gilford progeria is a biomarker of cellular aging in human skin. PLoS ONE 2:e1269. doi: 10.1371/journal.pone.0001269
118. Mehandru, S., Poles, M. A., Tenner-Racz, K., Horowitz, A., Hurley, A., Hogan, C., et al. (2004). Primary HIV-1 infection is associated with preferential depletion of CD4+T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 200, 761-770. doi: 10.1084/jem.20041196
119. Miller, J. D., Ganat, Y. M., Kishinevsky, S., Bowman, R. L., Liu, B., Tu, E. Y., et al. (2013). Human iPSC-based modeling of late-onset disease via progerin-induced aging. Cell Stem Cell 13, 691-705. doi: 10.1016/j.stem.2013.11.006
120. Minear, S., Leucht, P., Jiang, J., Liu, B., Zeng, A., Fuerer, C., et al. (2010). Wnt proteins promote bone regeneration. Sci. Transl. Med. 2, 29ra30. doi: 10.1126/scitranslmed.3000231
121. Mitalipov, S., and Wolf, D. (2009). Totipotency, pluripotency and nuclear reprogramming. Adv. Biochem. Eng. Biotechnol. 114, 185-199. doi: 10.1007/10_2008_45
122. Mohamet, L., Miazga, N. J., and Ward, C. M. (2014). Familial Alzheimer's disease modeling using induced pluripotent stem cell technology. World J. Stem Cells 6, 239-247. doi: 10.4252/wjsc.v6.i2.239
123. Munoz-Najar, U., and Sedivy, J. M. (2011). Epigenetic control of aging. Antioxid. Redox Signal. 14, 241-259. doi: 10.1089/ars.2010.3250
124. Natsuka, S., Akira, S., Nishio, Y., Hashimoto, S., Sugita, T., Isshiki, H., et al. (1992). Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin-6. Blood 79, 460-466
125. Niu, W., Zang, T., Zou, Y., Fang, S., Smith, D. K., Bachoo, R., et al. (2013). In vivo reprogramming of astrocytes to neuroblasts in the adult brain. Nat. Cell Biol. 15, 1164-1175. doi: 10.1038/ncb2843
126. Niwa, H., Miyazaki, J., and Smith, A. G. (2000). Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24, 372-376. doi: 10.1038/74199
127. Okita, K., Ichisaka, T., and Yamanaka, S. (2007). Generation of germline-competent induced pluripotent stem cells. Nature 448, 313-317. doi: 10.1038/nature05934
128. Pajcini, K. V., Corbel, S. Y., Sage, J., Pomerantz, J. H., and Blau, H. M. (2010). Transient inactivation of Rb and ARF yields regenerative cells from postmitotic mammalian muscle. Cell Stem Cell 7, 198-213. doi: 10.1016/j.stem.2010.05.022
129. Pandian, G. N., Taniguchi, J., and Sugiyama, H. (2014). Cellular reprogramming for pancreatic beta-cell regeneration: clinical potential of small molecule control. Clin. Transl. Med. 3:6. doi: 10.1186/2001-1326-3-6
130. Papp, B., and Plath, K. (2011). Reprogramming to pluripotency: stepwise resetting of the epigenetic landscape. Cell Res. 21, 486-501. doi: 10.1038/cr.2011.28
131. Papp, B., and Plath, K. (2013). Epigenetics of reprogramming to induced pluripotency. Cell 152, 1324-1343. doi: 10.1016/j.cell.2013.02.043
132. Parson, A. (2006). The long journey from stem cells to medical product. Cell 125, 9-11. doi: 10.1016/j.cell.2006.03.024
133. Patel, M., and Yang, S. (2010). Advances in reprogramming somatic cells to induced pluripotent stem cells. Stem Cell Rev. 6, 367-380. doi: 10.1007/s12015-010-9123-8
134. Phillips, T. (2008). The role of methylation in gene expression. Nat. Educ. 1:116
135. Porrello, E. R., and Olson, E. N. (2014). A neonatal blueprint for cardiac regeneration. Stem Cell Res. doi: 10.1016/j.scr.2014.06.003. [Epub ahead of print]
136. Qu, F., Wang, F. F., Yin, R., Ding, G. L., El-Prince, M., Gao, Q., et al. (2012). A molecular mechanism underlying ovarian dysfunction of polycystic ovary syndrome: hyperandrogenism induces epigenetic alterations in the granulosa cells. J. Mol. Med. (Berl.) 90, 911-923. doi: 10.1007/s00109-012-0881-4
137. Radzisheuskaya, A., and Silva, J. C. (2014). Do all roads lead to Oct4? the emerging concepts of induced pluripotency. Trends Cell Biol. 24, 275-284. doi: 10.1016/j.tcb.2013.11.010
138. Rando, T. A., and Chang, H. Y. (2012). Aging, rejuvenation, and epigenetic reprogramming: resetting the aging clock. Cell 148, 46-57. doi: 10.1016/j.cell.2012.01.003
139. Richter, H., Randau, L., and Plagens, A. (2013). Exploiting CRISPR/Cas: interference mechanisms and applications. Int. J. Mol. Sci. 14, 14518-14531. doi: 10.3390/ijms140714518
140. Rivera, C. M., and Ren, B. (2013). Mapping human epigenomes. Cell 155, 39-55. doi: 10.1016/j.cell.2013.09.011
141. Rodenhiser, D., and Mann, M. (2006). Epigenetics and human disease: translating basic biology into clinical applications. CMAJ 174, 341-348. doi: 10.1503/cmaj.050774
142. Rutherford, R. B., Niekrash, C. E., Kennedy, J. E., and Charette, M. F. (1992). Platelet-derived and insulin-like growth factors stimulate regeneration of periodontal attachment in monkeys. J. Periodont. Res. 27, 285-290
143. Samson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C. M., et al. (1996). Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382, 722-725. doi: 10.1038/382722a0
144. Sanchez Alvarado, A., and Yamanaka, S. (2014). Rethinking differentiation: stem cells, regeneration, and plasticity. Cell 157, 110-119. doi: 10.1016/j.cell.2014.02.041
145. Schwartz, S. D., Hubschman, J. P., Heilwell, G., Franco-Cardenas, V., Pan, C. K., Ostrick, R. M., et al. (2012). Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 379, 713-720. doi: 10.1016/S0140-6736(12)60028-2
146. Seol, Y. J., Kang, H. W., Lee, S. J., Atala, A., and Yoo, J. J. (2014). Bioprinting technology and its applications. Eur. J. Cardiothorac. Surg. 46, 342-348. doi: 10.1093/ejcts/ezu148
147. Sharma, R. P. (2005). Schizophrenia, epigenetics and ligand-activated nuclear receptors: a framework for chromatin therapeutics. Schizophr. Res. 72, 79-90. doi: 10.1016/j.schres.2004.03.001
148. Shen, H. R., Qiu, L. H., Zhang, Z. Q., Qin, Y. Y., Cao, C., and Di, W. (2013). Genome-wide methylated DNA immunoprecipitation analysis of patients with polycystic ovary syndrome. PLoS ONE 8:e64801. doi: 10.1371/journal.pone.0064801
149. Shyh-Chang, N., Zhu, H., Yvanka De Soysa, T., Shinoda, G., Seligson, M. T., Tsanov, K. M., et al. (2013). Lin28 enhances tissue repair by reprogramming cellular metabolism. Cell 155, 778-792. doi: 10.1016/j.cell.2013.09.059
150. Soza-Ried, J., and Fisher, A. G. (2012). Reprogramming somatic cells towards pluripotency by cellular fusion. Curr. Opin. Genet. Dev. 22, 459-465. doi: 10.1016/j.gde.2012.07.005
151. Spemann, H. (1938). Embryonic Development and Induction. New Haven, CT: Yale University Press
152. Sterneckert, J. L., Reinhardt, P., and Scholer, H. R. (2014). Investigating human disease using stem cell models. Nat. Rev. Genet. 15, 625-639. doi: 10.1038/nrg3764
153. Su, R. J., Baylink, D. J., Neises, A., Kiroyan, J. B., Meng, X., Payne, K. J., et al. (2013). Efficient generation of integration-free ips cells from human adult peripheral blood using BCL-XL together with Yamanaka factors. PLoS ONE 8:e64496. doi: 10.1371/journal.pone.0064496
154. Subramanyam, D. (2013). Cellular reprogramming-Turning the clock back. Reson. 18, 514-521. doi: 10.1007/s12045-013-0069-4
155. Suhr, S. T., Chang, E. A., Tjong, J., Alcasid, N., Perkins, G. A., Goissis, M. D., et al. (2010). Mitochondrial rejuvenation after induced pluripotency. PLoS ONE 5:e14095. doi: 10.1371/journal.pone.0014095
156. Svendsen, C. N. (2013). Back to the future: how human induced pluripotent stem cells will transform regenerative medicine. Hum. Mol. Genet. 22, R32-R38. doi: 10.1093/hmg/ddt379
157. Szabo, E., Rampalli, S., Risueno, R. M., Schnerch, A., Mitchell, R., Fiebig-Comyn, A., et al. (2010). Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 468, 521-526. doi: 10.1038/nature09591
158. Tachibana, M., Amato, P., Sparman, M., Gutierrez, N. M., Tippner-Hedges, R., Ma, H., et al. (2013). Human embryonic stem cells derived by somatic cell nuclear transfer. Cell 153, 1228-1238. doi: 10.1016/j.cell.2013.05.006
159. Takahashi, K. (2012). Cellular reprogramming-lowering gravity on Waddington's epigenetic landscape. J. Cell Sci. 125, 2553-2560. doi: 10.1242/jcs.084822
160. Takahashi, K., and Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676. doi: 10.1016/j.cell.2006.07.024
161. Takahashi, K., and Yamanaka, S. (2013). Induced pluripotent stem cells in medicine and biology. Development 140, 2457-2461. doi: 10.1242/dev.092551
162. Talluri, T. R., Kumar, D., Glage, S., Garrels, W., Ivics, Z., Debowski, K., et al. (2014). Non-viral reprogramming of fibroblasts into induced pluripotent stem cells by sleeping beauty and piggybac transposons. Biochem. Biophys. Res. Commun. 450, 581-587. doi: 10.1016/j.bbrc.2014.06.014
163. Tang, S., Yang, L., Tang, X., and Liu, M. (2014). The role of oxidized ATM in the regulation of oxidative stress-induced energy metabolism reprogramming of CAFs. Cancer Lett. 353, 133-144. doi: 10.1016/j.canlet.2014.07.028
164. Teperek, M., and Miyamoto, K. (2013). Nuclear reprogramming of sperm and somatic nuclei in eggs and oocytes. Reprod. Med. Biol. 12, 133-149. doi: 10.1007/s12522-013-0155-z
165. Terai, S., Ishikawa, T., Omori, K., Aoyama, K., Marumoto, Y., Urata, Y., et al. (2006). Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 24, 2292-2298. doi: 10.1634/stemcells.2005-0542
166. Trounson, A., Thakar, R. G., Lomax, G., and Gibbons, D. (2011). Clinical trials for stem cell therapies. BMC Med. 9:52. doi: 10.1186/1741-7015-9-52
167. Tsai, S. Y., Bouwman, B. A., Ang, Y. S., Kim, S. J., Lee, D. F., Lemischka, I. R., et al. (2011). Single transcription factor reprogramming of hair follicle dermal papilla cells to induced pluripotent stem cells. Stem Cells 29, 964-971. doi: 10.1002/stem.649
168. Unaids. (2013). 2013 Global Fact Sheet. Geneva: UNAIDS
169. Unternaehrer, J. J., and Daley, G. Q. (2011). Induced pluripotent stem cells for modeling human diseases. Philos Trans. R. Soc. Lond. B Biol. Sci. 366, 2274-2285. doi: 10.1098/rstb.2011.0017
170. Van Den Veyver, I. B., and Zoghbi, H. Y. (2001). Mutations in the gene encoding methyl-CpG-binding protein 2 cause Rett syndrome. Brain Dev. 23(Suppl. 1), S147-S151. doi: 10.1016/S0387-7604(01)00376-X
171. Van Oevelen, C., Kallin, E. M., and Graf, T. (2013). Transcription factor-induced enhancer modulations during cell fate conversions. Curr. Opin. Genet. Dev. 23, 562-567. doi: 10.1016/j.gde.2013.07.003
172. Vierbuchen, T., and Wernig, M. (2012). Molecular roadblocks for cellular reprogramming. Mol. Cell 47, 827-838. doi: 10.1016/j.molcel.2012.09.008
173. Villeda, S. A., Luo, J., Mosher, K. I., Zou, B., Britschgi, M., Bieri, G., et al. (2011). The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 477, 90-94. doi: 10.1038/nature10357
174. Wang, A., Tang, Z., Park, I. H., Zhu, Y., Patel, S., Daley, G. Q., et al. (2011). Induced pluripotent stem cells for neural tissue engineering. Biomaterials 32, 5023-5032. doi: 10.1016/j.biomaterials.2011.03.070
175. Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., et al. (2013). One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 153, 910-918. doi: 10.1016/j.cell.2013.04.025
176. Wang, K. C., Helms, J. A., and Chang, H. Y. (2009). Regeneration, repair and remembering identity: the three Rs of hox gene expression. Trends Cell Biol. 19, 268-275. doi: 10.1016/j.tcb.2009.03.007
177. Watanabe, A., Yamada, Y., and Yamanaka, S. (2013). Epigenetic regulation in pluripotent stem cells: a key to breaking the epigenetic barrier. Philos. Trans. R. Soc. Lond. B Biol. Sci. 368:20120292. doi: 10.1098/rstb.2012.0292
178. Weinhold, B. (2006). Epigenetics: the science of change. Environ. Health Perspect. 114, A160-A167. doi: 10.1289/ehp.114-a160
179. Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., et al. (2007). In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448, 318-324. doi: 10.1038/nature05944
180. Wu, D. C., Boyd, A. S., and Wood, K. J. (2007). Embryonic stem cell transplantation: potential applicability in cell replacement therapy and regenerative medicine. Front. Biosci. 12, 4525-4535. doi: 10.2741/2407
181. Yeh, E. T., Zhang, S., Wu, H. D., Korbling, M., Willerson, J. T., and Estrov, Z. (2003). Transdifferentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation 108, 2070-2073. doi: 10.1161/01.CIR.0000099501.52718.70
182. Yingze Zhao, Y. Y. A. Y. W. (2014). Developing CRISPR/Cas9 technologies for research and medicine. MOJ Cell Sci. Report 1, 7
183. Yonekawa, Y., and Kim, I. K. (2014). Clinical characteristics and current treatment of age-related macular degeneration. Cold Spring Harb. Perspect. Med. doi: 10.1101/cshperspect.a017178. [Epub ahead of print]
184. Zhao, T., Zhang, Z. N., Rong, Z., and Xu, Y. (2011). Immunogenicity of induced pluripotent stem cells. Nature 474, 212-215. doi: 10.1038/nature10135
185. Zhong, X., Gutierrez, C., Xue, T., Hampton, C., Vergara, M. N., Cao, L. H., et al. (2014). Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCs. Nat. Commun. 5, 4047. doi: 10.1038/ncomms5047
186. Zhou, Q., Brown, J., Kanarek, A., Rajagopal, J., and Melton, D. A. (2008). In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 455, 627-632. doi: 10.1038/nature07314
187. Zhu, H., Lensch, M. W., Cahan, P., and Daley, G. Q. (2011). Investigating monogenic and complex diseases with pluripotent stem cells. Nat. Rev. Genet. 12, 266-275. doi: 10.1038/nrg2951
188. Zs-Nagy, I., Cutler, R. G., and Semsei, I. (1988). Dysdifferentiation hypothesis of aging and cancer: a comparison with the membrane hypothesis of aging. Ann. N. Y. Acad. Sci. 521, 215-225